Abstract
This Frost & Sullivan research service titled Blockbusters Going off Patent -
Opportunities for Generics provides a detailed analysis of the European
generics market in light of various opportunities created by the patent expiry
of blockbuster drugs. It includes an overview on generics, market engineering
measurements, country-wise trend analysis, revenue forecasts, strategic
recommendations and decision support databases.
This analysis is available through our Pharmaceuticals and Biotechnology
Growth Partnership Services program. With this program, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
Table of Contents
1 BLOCKBUSTERS GOING OFF-PATENT, EXECUTIVE SUMMARY
2 BLOCKBUSTERS GOING OFF-PATENT, GLOSSARY OF TERMS
3 BLOCKBUSTERS GOING OFF-PATENT, EUROPEAN GENERICS MARKET
- Introduction
- Understanding Generic Drugs
- Importance of Generics
- Market Overview
- Scope and Segmentation
- Market Opportunity Analysis
- Research Methodology
4 MARKET ENGINEERING RESEARCH FOR THE EUROPEAN GENERICS MARKET
- Market Dynamics
- Market Engineering Measurements
- Industry Challenges
- Market Drivers
- Market Restraints
- Revenue Forecasts
- Trends by Segment
- Trends by Geographic Region
- Competitive Structure
- Market Share Analysis
- Market Consolidation Analysis
5 BLOCKBUSTERS GOING OFF-PATENT, COUNTRY-WISE TRENDS
- Germany
- Market Overview
- Revenue Forecasts
- The United Kingdom
- Market Overview
- Revenue Forecasts
- France
- Market Overview
- Revenue Forecasts
- Spain
- Market Overview
- Revenue Forecasts
- The Netherlands
- Market Overview
- Revenue Forecasts
- Italy
- Market Overview
- Revenue Forecasts
- Belgium
- Market Overview
- Revenue Forecasts
- Central and Eastern European Countries
- Market Overview and Future Trends
6 BLOCKBUSTERS GOING OFF-PATENT, STRATEGIC RECOMMENDATIONS
- Recommendations to Market Participants
7 BLOCKBUSTERS GOING OFF-PATENT, DECISION SUPPORT DATABASES
- DSDs
- Total Healthcare Expenditure
- Pharmaceutical R&D Expenditure
| 
